Current Options in the Diagnosis and Management of Acute Limb Ischemia

Karthikeshwar Kasirajan, MD, Kenneth Ouriel, MD

Prog Cardiovasc Nurs. 2002;17(1)

Classification of ALI

An ad hoc committee of the Society for Vascular Surgery and the North American Chapter of the International Society for Cardiovascular Surgery created a classification ( Table 1 ) for acute arterial occlusion.^[3] Three general classes are recognized:

Class I: Non-threatened extremity; elective revascularization may or may not be necessary.

Class II: Threatened extremity; revascularization is indicated to prevent tissue loss.

Class III: Ischemia has progressed to infarction and salvage of the extremity is not possible.

1 2 3 4 5 6 7 8 9 10

Next Section

References

Table 1. Clinical Categories of Acute Limb Ischemia
Category	Sensory Change	Motor Change	Doppler Signals
Category	Sensory Change	Motor Change	Arterial	Venous
Viable	None	None	Audible	Audible
Threatened	Rest pain	Moderate	Inaudible	Audible
Irreversible	Anesthetic	Paralysis	Inaudible	Inaudible

Table 2. Amputation, Mortality, and Long-Term Limb Salvage With Open Surgery
Author	Year	Number	Amputation	Mortality	Limb Salvage
Campbell et al.^[7]	1998	474	16%	22%	NR
Nypaver et al.^[8]	1998	71	7%	10%	1 year: 62%
Pemberton et al.^[9]	1999	107	12%	25%	2 years: 75%

NR=not reported

Table 3. Contraindications to Use of Pharmacologic Thrombolytic Agents
Absolute Contraindications
Active bleeding disorder Gastrointestinal bleeding within 10 days Cerebrovascular event within 6 months Intracranial or spinal surgery within 3 months Head injury within 3 months
Relative Contraindications
Major surgery or trauma within 10 days Hypertension (systolic >180 mm Hg or diastolic >110 mm Hg) Cardiopulmonary resuscitation within 10 days Puncture of noncompressible vessel Intracranial tumor Pregnancy Diabetic hemorrhagic retinopathy Recent eye surgery Hepatic failure Bacterial endocarditis

Table 4. Results of Treatment With Initial Thrombolytic Therapy or Primary Operation for Acute Limb Ischemia: Multicenter, Randomized Trials
Trial	Patients	Time Period	Thrombolytic Therapy		Primary Operation
Trial	Patients	Time Period	Amputation	Death	Amputation	Death
Rochester^[10]	114	12 months	18%	16%	18%	42%
STILE^[2]	393	6 months	12%	6.5%	11%	8.5%
TOPAS-II^[11]	544	12 months	15%	20%	13.1%	17%

Table 5. Amputation, Mortality, and Patency After Percutaneous Mechanical Thrombectomy
Author	Year	Number	Device	Amputation	Mortality	Patency
Silva et al.^[14]	1998	22	Angiojet	5%	14%	NR
Wagner et al.^[13]	1997	50	Angiojet	8%	0	1 year: 69%
Reekers et al.^[21]	1996	28	Hydrolyser	11%	0	1 month: 50%
Henry et al.^[15]	1998	41	Hydrolyser	0	0	1 month: 73%
Hopfner et al.^[12]	1999	51	Oasis	17.70%	8%	6 months: 54%
Rilinger et al.^[18]	1997	40	Amplatz	5%	0	NR
Tadavarthy et al.^[22]	1994	14	Amplatz	0	0	6 months: 43%

NR=not reported

Comments

Commenting is limited to medical professionals. To comment please Log-in.

Comments on Medscape are moderated and should be professional in tone and on topic. You must declare any conflicts of interest related to your comments and responses. Please see our Commenting Guide for further information. We reserve the right to remove posts at our sole discretion.

Return to Article

Post as:

processing....

Current Options in the Diagnosis and Management of Acute Limb Ischemia

Classification of ALI

Comments

Most Popular Articles

What to Read Next on Medscape

Special Coverage: COVID-19

About

Membership

Apps

WebMD Network

Editions

Current Options in the Diagnosis and Management of Acute Limb Ischemia

Classification of ALI

Tables

Tables

Tables

Tables

Tables

References

Authors and Disclosures

Authors and Disclosures

Comments

Most Popular Articles

What to Read Next on Medscape

Special Coverage: COVID-19

Recommended Reading

Drugs Related to null

Most Popular Articles

Email This

Find Us On

About

Membership

Apps

WebMD Network

Editions